The INFORMS Analytics+ Conference showcased how companies are turning advanced analytics and AI into measurable operational results
Museums take this educational role seriously, and many institutions understand the need to sustain and broaden their appeal. “They used to be these big ivory towers of knowledge and history and thought and art,” said Hilary Knight, director of Change& in London and former director of digital at Tate. “Museums themselves are changing their role to be centers for discussion and encounter and to be much more participatory.”
President Donald Trump is back at it with his tariff threats for pharma, promising massive levies on generic drug imports starting in 2028.
The president’s proposal — which was announced on Truth Social and has yet to be solidified via an official proclamation or notice — is framed as a push to encourage domestic drug manufacturing.
Trump outlined a 100% tariff on generic drugs originating from outside the U.S. starting on Aug. 1, 2028, which would be increased to 200% the following year.
But the conditions that have long kept generic drug manufacturing out of the U.S. largely haven’t changed and Trump’s most recent plan might only succeed in making drugs more expensive while failing to bring factories stateside, according to Tinglong Dai, the Bernard T. Ferrari professor of business at Johns Hopkins Carey Business School.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
When elected officials control the maps, they are not just participating in democracy. They are engineering the habitat in which democracy thrives or languishes. That makes redistricting not only a political problem, but also an operations research problem.
A computerized matching system can be designed to be fair and still produce unequal outcomes if the people using it do not understand how it works.
We are drowning in numbers, and we no longer understand what they mean. Every day, headlines bombard us with figures meant to inform: billions in spending, trillions in debt, percentages signaling growth or decline. But for most of us, these numbers blur together. They register as “large” or “small,” but almost never as real. And that is more than a math problem. It is a civic one.
Big data, artificial intelligence and advanced pricing algorithms make it easier than ever for companies to fine-tune prices for individual products to closely reflect their unique value and cost. The conventional wisdom is straightforward: better data, better algorithms and sharper segmentation should produce better profits. But new research suggests that the most profitable answer isn’t always more fine-grained pricing across a product line. In fact, it is fewer, better-chosen price points.
INFORMS has awarded Microsoft (NASDAQ: MSFT) its 2026 Franz Edelman Award for Achievement in Advanced Analytics, Operations Research and Management Science, for reengineering how global cloud infrastructure is planned and delivered, applying advanced analytics and AI to orchestrate complex fulfillment decisions across its rapidly expanding data center network.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine